• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

michael.menden@unimelb.edu.au

Credentials


Position
Associate Professor in Biochemistry & Pharmacology
Department of Biochemistry and Pharmacology
Education
PhD
University of Cambridge
ORCID

0000-0003-0267-5792

A/Prof Michael Menden

Associate Professor in Biochemistry & Pharmacology
Department of Biochemistry and Pharmacology

87 Scholarly works
9 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Systematic identification of pan-cancer single-gene expression biomarkers in drug high-throughput screens
    DOI: 10.1371/journal.pone.0330412
  • 2026

    Journal article

    Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasis.
    DOI: 10.1093/bjd/ljag154
  • 2026

    Journal article

    Neutralizing IL-22RA1 improves histologic and molecular alterations associated with atopic dermatitis pathogenesis
    DOI: 10.1016/j.jaci.2025.08.033
  • 2026

    Journal article

    MiR-940 Suppresses Ferroptosis by Controlling Expression of Key Regulatory Genes
    DOI: 10.1002/advs.75830
  • 2026

    Research grants (other domestic)

    Creating a Device-Agnostic Model for Inclusive Symptom Tracking in Chronic Conditions
  • 2025

    Research grants (other domestic)

    Predicting Post-Exertional Malaise in ME/CFS With Digital Biomarkers
  • 2024

    Research grants (ARC, NHMRC, MRFF)

    Accelerated Drug Discovery Using Population Wide Screening of Patient iPSC\2019s for MND
Michael Menden

Latest Honours,
Awards and Fellowships


2022
McGuigan Drug Discovery Rising Star Prize University of Cardiff
2020
European Research Council (ERC) Starting Grant European Research Council
2018
AstraZeneca Award for driving successful external oncology collaborations AstraZeneca
2017
AstraZeneca Leadership Team Recognition Award AstraZeneca

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Periodic fasting induced reconstitution of metabolic flexibility improves albuminuria in patients with type 2 diabetes
    DOI: 10.1016/j.molmet.2025.102257
  • 2025

    Journal article

    LUBAC modulates CBM complex functions downstream of TRAF6 in T cells
    DOI: 10.1038/s41467-025-65879-6
  • 2025

    Journal article

    Large language models forecast patient health trajectories enabling digital twins
    DOI: 10.1038/s41746-025-02004-3
  • 2025

    Journal article

    Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS study
    DOI: 10.1186/s42466-025-00417-9
  • 2025

    Journal article

    Single cell spatial transcriptomics integration deciphers the morphological heterogeneity of atherosclerotic carotid arteries
    DOI: 10.1038/s41467-025-67679-4
  • 2025

    Journal article

    Technological advances in the search for a CURE for asthma
    DOI: 10.5694/mja2.70084

RECENT PROJECTS

  • 2026

    Research grants (ARC, NHMRC, MRFF)

    The CURE Asthma Data Integration Research Engine (CURE-ADIRE)
  • 2026

    Research grants (other domestic)

    Towards Early Diagnosis: Uncovering Biomarkers of Colorectal Cancer in Adults With Cystic Fibrosis

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224